open access

Vol 81, No 9 (2010)
ARTICLES
Get Citation

Do chromosomal abnormalities reappear in subsequent pregnancies and how often?

Jana Skrzypczak, Barbara Kwinecka-Dmitriew, Monika Zakrzewska, Anna Latos-Bieleńska
Ginekol Pol 2010;81(9).

open access

Vol 81, No 9 (2010)
ARTICLES

Abstract

Abstract Objective: Genetic factors are the most common causes of spontaneous abortions. 50% to 80% of first-trimester abortions reveal chromosome abnormalities. Evidence for the recurrence of the same or another chromosome abnormality in the next pregnancy is scarce. The aim: The aim of our study was to estimate recurrence risk of abortus aneuploidy and to find out whether karyotyping of the abortus allows the prognose subsequent pregnancy outcomes. Material and methods: Paraffin-embedded chorions have undergone cytogenetic examination using FISH with chromosome-specific probes. 57 chorions from 26 women have been assessed, including chorions from two consecutive abortions from 18 women and chorions from three consecutive abortions from 5 women. Results: 38.6% of 57 specimens had chromosome aberrations. The most prevalent anomalies were 16, 21 and 18 trisomies. 23 patients had a subsequent abortion karyotyped; 15 had a normal initial karyotype and 8 had an aberrant initial karyotype. 3 out of the 8 patients had a repeated chromosome anomaly. 5 out of the 15 patients who initially miscarried an aneuploid embryo, had a subsequent miscarriage of an aneuploid embryo. Only 3 (13.04%) out of the 23 patients displayed aneuploidy in each abortus. Conclusion: 1. Chromosome aberrations can reappear in subsequent pregnancies in the same patient and may be the cause of recurrent miscarriages. 2. The value of embryo/fetal karyotyping is not decisive in prognosis of subsequent pregnancy outcome. 3. Abnormal fetal karyotype can occur regardless of other causes of pregnancy loss.

Abstract

Abstract Objective: Genetic factors are the most common causes of spontaneous abortions. 50% to 80% of first-trimester abortions reveal chromosome abnormalities. Evidence for the recurrence of the same or another chromosome abnormality in the next pregnancy is scarce. The aim: The aim of our study was to estimate recurrence risk of abortus aneuploidy and to find out whether karyotyping of the abortus allows the prognose subsequent pregnancy outcomes. Material and methods: Paraffin-embedded chorions have undergone cytogenetic examination using FISH with chromosome-specific probes. 57 chorions from 26 women have been assessed, including chorions from two consecutive abortions from 18 women and chorions from three consecutive abortions from 5 women. Results: 38.6% of 57 specimens had chromosome aberrations. The most prevalent anomalies were 16, 21 and 18 trisomies. 23 patients had a subsequent abortion karyotyped; 15 had a normal initial karyotype and 8 had an aberrant initial karyotype. 3 out of the 8 patients had a repeated chromosome anomaly. 5 out of the 15 patients who initially miscarried an aneuploid embryo, had a subsequent miscarriage of an aneuploid embryo. Only 3 (13.04%) out of the 23 patients displayed aneuploidy in each abortus. Conclusion: 1. Chromosome aberrations can reappear in subsequent pregnancies in the same patient and may be the cause of recurrent miscarriages. 2. The value of embryo/fetal karyotyping is not decisive in prognosis of subsequent pregnancy outcome. 3. Abnormal fetal karyotype can occur regardless of other causes of pregnancy loss.
Get Citation

Keywords

miscarriage, paraffin - embedding, cytogenetica

About this article
Title

Do chromosomal abnormalities reappear in subsequent pregnancies and how often?

Journal

Ginekologia Polska

Issue

Vol 81, No 9 (2010)

Bibliographic record

Ginekol Pol 2010;81(9).

Keywords

miscarriage
paraffin - embedding
cytogenetica

Authors

Jana Skrzypczak
Barbara Kwinecka-Dmitriew
Monika Zakrzewska
Anna Latos-Bieleńska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl